Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
RaySearch Laboratories AB ( ($SE:RAY.B) ) has provided an update.
RaySearch Laboratories AB announced that it will release its interim report for the third quarter of 2025 on November 7, followed by a webcast presentation. The presentation, led by CEO Johan Löf and CFO Nina Grönberg, will provide insights into the company’s performance and will include a Q&A session. This event is significant for stakeholders as it offers an opportunity to engage with the company’s leadership and gain a deeper understanding of its financial health and strategic direction.
The most recent analyst rating on ($SE:RAY.B) stock is a Hold with a SEK274.00 price target. To see the full list of analyst forecasts on RaySearch Laboratories AB stock, see the SE:RAY.B Stock Forecast page.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a medical technology company specializing in innovative software solutions for cancer treatment. The company offers products such as the RayStation treatment planning system, RayCare oncology information system, RayIntelligence oncology analytics system, and RayCommand treatment control system. RaySearch’s software is utilized by over 1,100 clinics across 47 countries, and the company has been publicly listed on Nasdaq Stockholm since 2003.
Average Trading Volume: 124,068
Technical Sentiment Signal: Hold
Current Market Cap: SEK7.75B
Find detailed analytics on RAY.B stock on TipRanks’ Stock Analysis page.